CD163 is known to be a characteristic marker of M2-type macrophages, which are considered to be immune cells involved in tumor growth and metastasis, and its activities include the induction of angiogenesis, inhibition of T-cell activity, and release of chemokines such as inflammatory growth factors, for the promotion of tumor cell growth. Here, CD163 is linked to neoplasm.